May 14, 2020
Ian Wyatt is the President of Wyatt Investment Research. He has been helping regular investors uncover hidden growth opportunities by beating the market and finding great investments at attractive prices. Ian has been actively investing in the stock market for the past 30 years. He's also spent more than 20 years publishing his investment ideas online to help fellow investors benefit from his successes and failures.
Ian Wyatt is also the host of the Daily Profit Podcast.
Pharmaceutical companies in the US and in other parts of the world are racing against time to develop a vaccine and a cure for COVID-19. There is a lot of optimism behind drugs like Remdesivir from Gilead Science because of the promising results it showed after they were tested on COVID-19 patients.
On the economic side, some US States have started reopening for business although unemployment rates are still high. This is expected to continue for a few more months as some companies choose to work from home with a reduced workforce. But despite this, stocks are continuously rising and this is a question mark for many observers.
In this episode of the Daily Profit Show, Ian Wyatt shares his insights on the continuing worldwide saga on COVID-19 through a webinar he held with his clients last April 29 2020. Tune in as he discusses the optimism behind a promising drug for COVID0-19, the actions of the Federal Reserve and what it could mean for everyone, and the importance of mass testing before reopening. He also discusses the current state of the oil industry and why stocks are rising despite businesses going on pause so stay tuned.